Agaricus blazei (Royal Sun Mushroom) trials recruiting now

1 registration that name agaricus blazei as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 1 registration

Status

1US sites across 1 state

All 1 registrations

RecruitingNCT07195552

Clinical Trial: Rapid Immune Modulating Effects

  • No phase
  • Natural Immune Systems Inc
  • About 12 people
  • Started Jul 1, 2024

In plain words A study of agaricus blazei in people 18 to 75, run by Natural Immune Systems Inc. It plans to enroll about 12 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 75; healthy volunteers accepted. Conditions: Immune Surveillance.

  • Healthy adults;
  • Age 18-75 years (inclusive);
  • Veins easy to see in one or both arms (to allow for the multiple blood draws);
  • Willing to comply with study procedures, including:

5 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Agaricus blazei; Reishi; Turkey Tail; Placebo

Registered summary

The goal for this clinical trial is to compare the immune effects of three different medicinal mushrooms to a placebo. The mushrooms include Agaricus, Reishi, and Turkey Tail.

Where, as registered

1 US site in 1 state.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.